To understand the molecular features of the interactions of neutralizing nAbs with the S protein, we characterized ten nAbs derived from COVID-19 convalescents with strong binding and neutralizing activities, and the capacity of competing with ACE2 for RBD binding. The gene discussed is PROS1; the disease is COVID-19.